Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >DB2313
DB2313
  • DB2313

DB2313 NEW

Price $50 $122 $197
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: DB2313 CAS No.: 2170606-74-1
Purity: 99.73% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NameDB2313
DescriptionDB2313 (Carboximidamide) is a potent transcription factor PU.1 inhibitor, IC50=14 nM. DB2313 disrupts the interaction of PU.1 with target gene promoters. DB2313 induces apoptosis of acute myeloid leukemia (AML) cells, and has anticancer effects
In vitroDB2313 reduces PU.1 binding to the promoters of E2f1, Junb, and Csf1r in acute myeloid leukemia (AML) cells, significantly impairing their proliferation, particularly in PU.1 URE–/– AML cells where it shows an IC50 of 7.1 μM with minimal impact on normal hematopoietic cells at comparable doses. This treatment also increases apoptosis by 3.5 times in PU.1 URE–/– AML murine cells and notably diminishes their clonogenic survival across successive replatings, culminating in a total loss of clonogenic capacity from the fourth replating onwards[1].
In vivoDB2313 (17 mg/kg; i.p.; three times per week for 3 weeks) treatment reduces leukemia progression and enhances survival in mice.
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationDMSO : 3 mg/mL (4.2 mM), Sonication and heating to 70℃ are recommended.
KeywordsDB-2313 | DB2313 | DB 2313
Inhibitors RelatedStavudine | 5-Fluorouracil | Acetylcysteine | Kaempferol | Myricetin | Sodium 4-phenylbutyrate | L-Ascorbic acid | Dextran sulfate sodium salt (MW 4500-5500) | Metronidazole | Sorafenib | Tributyrin | Lidocaine hydrochloride
Related Compound LibrariesBioactive Compound Library | Inhibitor Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$2180.00/50mg
VIP1Y
TargetMol Chemicals Inc.
2024-10-28
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hills
INQUIRY